Surmodics Inc
NASDAQ:SRDX
Operating Margin
Surmodics Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Surmodics Inc
NASDAQ:SRDX
|
400.4m USD |
-4%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226.4B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.7B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.7B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.6B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.8B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
60.1B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.3B USD |
29%
|
Surmodics Inc
Glance View
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Surmodics Inc's most recent financial statements, the company has Operating Margin of -4.4%.
You don't have any saved screeners yet